Analyst Ratings for ProQR Therapeutics N.V. (PRQR) [Buys]
PRQR Rating Summary
PRQR Price Target Summary
- Highest: $4.50 (Cantor Fitzgerald)
- Lowest: $2.10 (Citi)
- Average: $3.03
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.03 (+53.2%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$3.03 (+53.2%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/8/2023 | Chardan Capital Markets » Updated 3/14/2024 |
Keay Nakae | Upgrade | Buy (Neutral) |
2.50 (2.00) |
1.22 (1.98) |
62.3% | Details |
| 3/30/2023 | JMP Securities | Jonathan Wolleben | Upgrade | Market Outperform (Market Perform) |
6.00 (N/A) |
3.58 (1.98) |
-44.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
